Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H16Cl3N3O4S |
InChIKeyHAAITRDZHUANGT-FYZYNONXSA-N |
CAS Registry583057-49-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Candidiasis | Phase 2 | - | - | |
Candidiasis, Vulvovaginal | Discovery | FR | 11 Jun 2010 |
Phase 2 | 229 | (Placebo) | citacdgcef(vcjlkedwcd) = haucvkbnzv gefctipjeu (mgvntdsvqw, mzyglfzgrs - swktswsrko) View more | - | 09 Oct 2013 | ||
placebo+arasertaconazole nitrate (Arasertaconazole Nitrate 150 mg) | citacdgcef(vcjlkedwcd) = sqthyqukhp gefctipjeu (mgvntdsvqw, zbwmlosknd - hrdykwbwnn) View more |